← The Lantern · New Carlisle
health · class ii

Agilent Technologies Denmark ApS recalls FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) and 2 other products

FDA assigned 3 recall numbers to the action, one per product; all of them are listed with this filing.

Illustration: a small clinic exam room with an exam table, a stethoscope and a clipboard
Illustration · The Lantern

Agilent Technologies Denmark ApS began a medical device recall on August 11, 2025 whose reported distribution included Ohio. FDA

What the record shows

The stated reason: Their is the potential for weak staining which may result in false negative CD20 identification. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 4145. The recall is listed as ongoing. FDA

1 source

Context

This is one of 13 records of this type (Class Ii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2880 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: August 11, 2025 FDA
  • Recall number: Z-2563-2025 FDA
  • Recalls in this action: 3 FDA
  • Recalling firm: Agilent Technologies Denmark ApS FDA
  • Product: Brand Name: FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) Model/Catalog Number… FDA
  • Reason for recall: Their is the potential for weak staining which may result in false negative CD20 identification. FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberZ-2563-2025
Recalls in this action3
Recalling firmAgilent Technologies Denmark ApS
ProductBrand Name: FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) Model/Catalog Number: GA60461-2 Software Version: Not applicable Product Description: FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis) is intended for use in immunohistochemistry together with the Dako Omnis instrument. This antibody labels cells of the B-cell lineage and is a useful aid for the classification of neoplasms of B-cell derivation. Component: Not applicable
Reason for recallTheir is the potential for weak staining which may result in false negative CD20 identification.
ClassificationClass II — use may cause temporary or medically reversible health consequences
Recall typemedical device
Quantity4145
StatusOngoing
Voluntary or mandatedVoluntary: Firm initiated
Initiated20250811
Reported20250924
DistributionUS Nationwide distribution including in the states of Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia, Wiscon
Firm locationGlostrup, N/A, Denmark
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.